Addus HomeCare Corporation — Form 10-Q Summary
Period mismatch: The request metadata says 2019 Q3, but the supplied filing is for the three months ended March 31, 2020 (first quarter 2020), signed August 10, 2020. The summary below reflects the filing text.
Business context and reporting period
Addus provides personal care, hospice, and home health services across 26 states through 195 offices. It served approximately 49,000 individuals in the quarter, versus approximately 43,000 a year earlier. The company’s payors include government programs, managed care organizations, insurers, and private-pay customers.
Financial performance and liquidity
| Metric | Q1 2020 | Q1 2019 |
|---|---|---|
| Net service revenue | $190.2 million | $138.5 million |
| Gross profit / margin | $55.8 million / 29.4% | $36.8 million / 26.6% |
| Operating income | $10.7 million | $5.5 million |
| Net income | $8.7 million | $4.3 million |
| Diluted earnings per share | $0.54 | $0.32 |
| Operating cash flow | $20.4 million | $(3.2) million |
Revenue increased 37.3% year over year. Personal care billable hours rose 11.8% and revenue per billable hour rose 12.6%; acquisitions made in 2019 also contributed materially to growth. Gross margin improved, which management attributed mainly to the acquired businesses’ higher margins. General and administrative expense increased to $42.3 million from $29.3 million, and rose to 22.2% of revenue from 21.1%.
At March 31, 2020, cash was $130.5 million, total current assets were $278.1 million, and current liabilities were $84.6 million. Debt was approximately $62.3 million in outstanding credit-facility borrowings, plus immaterial financing leases; the balance-sheet carrying value of total debt was $60.1 million after issuance costs. The company had $218.5 million of available revolving capacity and reported compliance with financial covenants. Cash increased $18.7 million during the quarter. Operating cash flow benefited in part from lower receivables, including a reduction in the Illinois Department on Aging receivable.
Material changes, outlook, and risks
- Personal care revenue grew 25.6%; hospice revenue grew 218.5%, primarily reflecting acquisitions; home health revenue grew 60.9%, also partly reflecting acquisitions. Hospice segment operating margin declined to 25.5% from 32.3%, while personal care and home health segment margins improved.
- The 2019 comparison was revised for prior-period errors in estimating implicit price concessions and related tax items. Q1 2019 revenue was reduced by $0.7 million and net income by $0.6 million; cumulative retained earnings at January 1, 2019 was reduced by $7.0 million. Management said prior statements were not materially misstated, but recording all corrections in 2019 would have materially misstated that year.
- COVID-19’s ultimate effects were uncertain. The company reported about $0.3 million of COVID-related costs in Q1 and said services were designated essential; it could not estimate total future costs. Management warned that state budget pressure, reimbursement changes, workforce and supply disruptions, and higher operating costs could affect results, cash flows, and liquidity. It also said the pandemic’s financial effect could not be reasonably estimated at the time.
- Illinois represented 37.7% of quarterly revenue; the Illinois Department on Aging alone represented 23.2%. Delayed state payments and budget constraints remain risks. The company reported 68 days sales outstanding at quarter-end, down from 72 days at year-end.
- The filing provides no formal earnings or revenue guidance. It describes reimbursement and labor-rate changes, including Illinois rate increases, but future funding or offsetting increases are not assured. The company cautioned that acquisitions were being pursued with additional care amid COVID-19.
- In April, Addus received $6.9 million in automatic federal relief-fund payments for which it had not applied and returned the funds in June. It acquired A Plus Health Care for approximately $12.2 million on July 1, after quarter-end.
- Disclosure controls and procedures were deemed ineffective as of March 31, 2020 because of material weaknesses previously disclosed in the 2019 Form 10-K. The company also obtained lender consent to extend the deadline for delivery of audited 2019 financial statements to October 31, 2020 after it could not file its 10-K on time.
Important facts for investors to verify
- Confirm the intended reporting period: the supplied filing is Q1 2020, not Q3 2019.
- Review remediation of the disclosed material weaknesses and the status of timely, reliable financial reporting.
- Track state reimbursement and collection trends, especially Illinois exposure and the impact of state budget shortfalls.
- Assess whether acquisition-driven revenue growth converts into sustained segment profitability and cash generation.
- Monitor COVID-related costs, reimbursement support, workforce availability, and any effects on consumer demand or state funding.
- Verify covenant compliance, borrowing availability, and progress on delivery of the audited 2019 financial statements.